PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00088660
Recruitment Status : Unknown
Verified February 2006 by Therion Biologics Corporation.
Recruitment status was:  Active, not recruiting
First Posted : August 2, 2004
Last Update Posted : February 8, 2006
Information provided by:
Therion Biologics Corporation

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Study Completion Date : No date given